MSC EVs
MSC Extracelluar Vesicles for Anti-Inflammation
MSC Extracelluar Vesicles Therapy for Inflammation – Patent and Application.
Our proprietary MSC-derived extracelluar vesicles (EVs)-technology is designed to treat inflammation. It leverages the natural anti-inflammatory and regenerative properties of MSC EVs. This technology enhances the therapeutic potential of EVs in mitigating lung injury, reducing inflammatory responses, and improving functional outcomes. Notably, our anti-inflammatory MSC-EVs exhibits potent immunomodulatory properties, enabling the regulation of macrophage polarization. They facilitate the transition of immune macrophages from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, thereby demonstrating substantial clinical potential for therapeutic applications.
